- A post-approval study of the Guidant Carotid stent systems and embolic protection systems (Carotid RX ACCULINK/RX ACCUNET Post- Approval Trial to Uncover Unanticipated or Rare Events – “CAPTURE 2”)
- An Observational, Prospective Evaluation of the Trifecta™ Valve
- ENDURANT STENT GRAFT SYSTEM US CLINICAL STUDY
- PROTOCOL 06-374 XIENCE™ V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study
- Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatiN (SATURN)
- SPIRIT IV Clinical Trial:A Clinical Evaluation of the XIENCE™ V Everolimus Eluting Coronary Stent System in the Treatment of Subjects with de novo Native Coronary Artery Lesions
- A Prospective Evaluation in a non-Randomized Trial of the Safety and Efficacy of the Use of the TAXUS® ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions in Small Vessels
- A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS® ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions
- A Randomised, Double-Blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
Reporting Concerns | PRIVACY POLICY | Terms of Service | Online Bill Pay | Mobile Site
Site optimized for Chrome or Firefox | Copyright © 2013. Sarasota Memorial Health Care System. All rights reserved.
Site optimized for Chrome or Firefox | Copyright © 2013. Sarasota Memorial Health Care System. All rights reserved.